Search results for: 'Shift from PSTN to IP'

This study highlights opportunities and risks in diagnostics/companion diagnostics sector from patenting perspective. It provides an overview of key intellectual property (IP) issues, recent cases for diagnostics and gene patenting in the United States and their business impact. It also provides an overview of the patenting activity in the area of ...

This analysis explores the transformation of healthcare from reactive disease treatment toward proactive, continuous, and personalized health management driven by AI, digital health, and predictive intelligence. Rising chronic disease burdens, aging populations, and escalating healthcare costs are accelerating demand for early detection, continuous...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the syn...

The report describes how predictive biomarkers are changing the global landscape of neuroregeneration and transitioning from the concept of control of brain injury to an active repair of the brain. This report describes how brain injuries from scans were being replaced by blood tests being developed to measure the burden of Alzheimer's disease, mea...

17 Mar 2020  |  North America  |  Market Research

Analysis of the Critical Care Patient Monitoring Market, US and EU5, Forecast to 2024

Market to Shift from Stand-alone Monitors to Integrated Solutions and Reach a Size of $13.17 Billion in 2024

Infographics

×

Key Issues Addressed

The economic burden for global critical care is estimated at $270 billion and intensive care unit (ICU) mortality in developed countries is still in the range of 10% to 20%. Advancements in effective patient monitoring in the ICU can not only help reduce the mortality rate but also be beneficial in improving patient and healthcare staff experience....